摘要
目的探讨经尿道膀胱肿瘤切除术治疗膀胱癌的临床疗效与安全性。方法方便选取2012年1月—2018年6月该院泌尿外科42例膀胱癌患者为研究对象,依据治疗方法不同分为实验组(经尿道膀胱肿瘤切除术,21例)和对照组(膀胱部分切除术,21例),对比观察两组治疗指标,术后随访,统计并发症及复发率。结果两组手术成功率均为100.00%;实验组手术时间(43.1±8.7)min、术中出血量(38.5±6.4)mL、术后住院时间(6.5±1.1)d、并发症发生率9.52%,各项指标均优于对照组,差异有统计学意义(t=5.746、9.857、3.277,χ~2=4.732;P<0.05);术后随访,实验组膀胱癌复发率(4.76%)与对照组(9.52%),差异无统计学意义(χ~2=2.417,P>0.05)。结论经尿道膀胱肿瘤切除术治疗膀胱癌效果确切,安全性高,利于患者术后早期恢复,值得临床推广使用。
Objective To investigate the clinical efficacy and safety of transurethral resection of bladder tumor in the treatment of bladder cancer. Methods From January 2012 to June 2018, 42 patients with bladder cancer in our hospital were convenient selected and enrolled in the study. According to the different treatment methods, they were divided into experimental group(transurethral resection of bladder tumor, 21 cases) and control group(partial resection of the bladder surgery,21 cases), comparative observation of two groups of treatment indicators, postoperative follow-up, statistical complications and recurrence rate. Results The success rate of the two groups was 100.00%. The operation time of the experimental group was(43.1±8.7) min, the intraoperative blood loss(38.5±6.4)mL, the postoperative hospital stay(6.5±1.1)d, and the complication rate was 9.52%. The indexes were superior to the control group, and the difference was statistically significant(t=5.746,9.857, 3.277,χ^2=4.732;P<0.05). The postoperative follow-up rate of bladder cancer in the experimental group(4.76%) and the control group(9.52%). There was no statistical difference between the two groups(χ^2=2.417, P >0.05). Conclusion Transurethral resection of bladder tumor is effective and safe in the treatment of bladder cancer, which is beneficial to the early recovery of patients. It is worthy of clinical promotion.
作者
郝宝金
徐峰
黄以顺
覃建迪
HAO Bao-jin;XU Feng;HUANG Yi-shun;TAN Jian-di(Department of Urology, Jinhu County People's Hospital, Huai'an, Jiangsu Province, 211600 China)
出处
《中外医疗》
2019年第7期99-101,共3页
China & Foreign Medical Treatment
